Biotech giant restructures operations as pandemic revenue boom fades
Biotech giant restructures operations as pandemic revenue boom fades Moderna, the US-based biotechnology firm behind one of the first mRNA Covid-19 vaccines, announced on Thursday it will cut approximately 10%…